900932:SSEShanghai Lujiazui Finance & Trade Zone Development Co., Ltd. Class B Analysis
Data as of 2026-03-17 - not real-time
$0.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock trades at $0.41, well below its 20‑day (0.421), 50‑day (0.421) and 200‑day (0.436) SMAs, with a bearish MACD histogram and an RSI of 38 indicating limited upside momentum. Volume is on a decreasing trend, and price is hovering near the identified support level of $0.403, suggesting short‑term pressure.
Fundamental backdrop: Valuation appears attractive – a trailing PE of 10.25 versus an industry average of 33, and a price‑to‑book of 0.56. However, the company carries an extreme debt‑to‑equity ratio of 138, a modest ROE of 3.9%, and a high dividend yield of 7.24% that may be unsustainable given earnings of $0.04 per share and a payout ratio of ~50%. The DCF model implies a fair value near $8.94, underscoring a massive valuation gap but also reflecting the risk of the leveraged balance sheet. Beta is very low at 0.09, yet 30‑day volatility sits at 16%, and the broader Chinese real‑estate sector faces heightened regulatory scrutiny.
Fundamental backdrop: Valuation appears attractive – a trailing PE of 10.25 versus an industry average of 33, and a price‑to‑book of 0.56. However, the company carries an extreme debt‑to‑equity ratio of 138, a modest ROE of 3.9%, and a high dividend yield of 7.24% that may be unsustainable given earnings of $0.04 per share and a payout ratio of ~50%. The DCF model implies a fair value near $8.94, underscoring a massive valuation gap but also reflecting the risk of the leveraged balance sheet. Beta is very low at 0.09, yet 30‑day volatility sits at 16%, and the broader Chinese real‑estate sector faces heightened regulatory scrutiny.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- Price below all major SMAs and near support
- Decreasing volume and bearish MACD
- High debt load limiting upside
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Significant valuation discount (PE 10.25 vs industry 33)
- Attractive dividend yield but sustainability concerns
- Potential stabilization of Chinese real‑estate policy
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Extreme leverage may constrain long‑run earnings
- Sector outlook remains uncertain amid regulatory reforms
- Low beta suggests limited market‑wide volatility exposure
Key Metrics & Analysis
Financial Health
Revenue Growth174.50%
Profit Margin7.66%
P/E Ratio10.3
ROE3.92%
ROA1.63%
Debt/Equity138.53
P/B Ratio0.6
Op. Cash Flow$4.2B
Free Cash Flow$4.3B
Industry P/E33.1
Technical Analysis
TrendBearish
RSI38.6
Support$0.40
Resistance$0.44
MA 20$0.42
MA 50$0.42
MA 200$0.44
MACDBearish
VolumeDecreasing
Fear & Greed Index81.11
Valuation
Fair Value$8.94
GradeUndervalued
TypeValue
Dividend Yield7.24%
Risk Assessment
Beta0.09
Volatility16.42%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.